OUR CEO
Welcome to Mid-Atlantic BioTherapeutics (MABT), where innovation meets compassion in the pursuit of transforming healthcare. At MABT, we are dedicated to advancing cutting-edge therapies for some of the most challenging neurological and infectious diseases facing society today.
At the heart of our innovation lies our advanced scientific approach. MABT combines deep expertise in biotechnology with state-of-the-art AI-driven computational methods to accelerate drug discovery and development. This interdisciplinary approach allows us to identify promising therapeutic targets more efficiently and design optimized therapies with enhanced precision.
This is not just science; it’s a journey of hope, compassion, and relentless dedication. I invite you to join us on this incredible journey.
-Dr. David Horn